Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 405-424
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.405
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.405
Figure 2 Immune targets and immune checkpoint inhibitors.
CTLA-4: Cytotoxic T lymphocyte-associated antigen 4; ICI: Immune checkpoint inhibitor; LAG3: Lymphocyte-activation gene 3; PD-1: Programmed cell death protein 1; PD-L1: Programmed death ligand 1; TIM3: T cell immunoglobulin and mucin domain containing-3.
- Citation: Luo YZ, Zhu H. Immunotherapy for advanced or recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(3): 405-424
- URL: https://www.wjgnet.com/1948-5204/full/v15/i3/405.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.405